Herpes Zoster Ophthalmicus Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: HD8D45BA8BBEEN
Market Monitor Global

Abstracts

Herpes Zoster Ophthalmicus is a diseases which activates itself due to the reoccurrence of varicella zoster virus infection. The disease involves eye and damages the eye and its surrounding structures due to inflammation of nerves.

This report contains market size and forecasts of Herpes Zoster Ophthalmicus Drug in Global, including the following market information:

Global Herpes Zoster Ophthalmicus Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Herpes Zoster Ophthalmicus Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Herpes Zoster Ophthalmicus Drug include Abbott, Novartis, GlaxoSmithKline, Fresenius, SteriMax, Cadila Pharmaceuticals, Shermco, TEVA and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Zoster Ophthalmicus Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Herpes Zoster Ophthalmicus Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Herpes Zoster Ophthalmicus Drug Market Segment Percentages, by Type, 2021 (%)

• Oral Drug
• Topical Drug
• Injectable Drug

Global Herpes Zoster Ophthalmicus Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Herpes Zoster Ophthalmicus Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Herpes Zoster Ophthalmicus Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Herpes Zoster Ophthalmicus Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Herpes Zoster Ophthalmicus Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Herpes Zoster Ophthalmicus Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Novartis
• GlaxoSmithKline
• Fresenius
• SteriMax
• Cadila Pharmaceuticals
• Shermco
• TEVA
• Cipla
• Mylan
• Foamix
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Herpes Zoster Ophthalmicus Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Herpes Zoster Ophthalmicus Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HERPES ZOSTER OPHTHALMICUS DRUG OVERALL MARKET SIZE

2.1 Global Herpes Zoster Ophthalmicus Drug Market Size: 2021 VS 2028
2.2 Global Herpes Zoster Ophthalmicus Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Herpes Zoster Ophthalmicus Drug Players in Global Market
3.2 Top Global Herpes Zoster Ophthalmicus Drug Companies Ranked by Revenue
3.3 Global Herpes Zoster Ophthalmicus Drug Revenue by Companies
3.4 Top 3 and Top 5 Herpes Zoster Ophthalmicus Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Herpes Zoster Ophthalmicus Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Herpes Zoster Ophthalmicus Drug Players in Global Market
  3.6.1 List of Global Tier 1 Herpes Zoster Ophthalmicus Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Herpes Zoster Ophthalmicus Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Herpes Zoster Ophthalmicus Drug Market Size Markets, 2021 & 2028
  4.1.2 Oral Drug
  4.1.3 Topical Drug
  4.1.4 Injectable Drug
4.2 By Type - Global Herpes Zoster Ophthalmicus Drug Revenue & Forecasts
  4.2.1 By Type - Global Herpes Zoster Ophthalmicus Drug Revenue, 2017-2022
  4.2.2 By Type - Global Herpes Zoster Ophthalmicus Drug Revenue, 2023-2028
  4.2.3 By Type - Global Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Herpes Zoster Ophthalmicus Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Herpes Zoster Ophthalmicus Drug Revenue & Forecasts
  5.2.1 By Application - Global Herpes Zoster Ophthalmicus Drug Revenue, 2017-2022
  5.2.2 By Application - Global Herpes Zoster Ophthalmicus Drug Revenue, 2023-2028
  5.2.3 By Application - Global Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Herpes Zoster Ophthalmicus Drug Market Size, 2021 & 2028
6.2 By Region - Global Herpes Zoster Ophthalmicus Drug Revenue & Forecasts
  6.2.1 By Region - Global Herpes Zoster Ophthalmicus Drug Revenue, 2017-2022
  6.2.2 By Region - Global Herpes Zoster Ophthalmicus Drug Revenue, 2023-2028
  6.2.3 By Region - Global Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Herpes Zoster Ophthalmicus Drug Revenue, 2017-2028
  6.3.2 US Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.3.3 Canada Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.3.4 Mexico Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Herpes Zoster Ophthalmicus Drug Revenue, 2017-2028
  6.4.2 Germany Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.4.3 France Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.4.4 U.K. Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.4.5 Italy Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.4.6 Russia Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.4.8 Benelux Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Herpes Zoster Ophthalmicus Drug Revenue, 2017-2028
  6.5.2 China Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.5.3 Japan Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.5.4 South Korea Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.5.6 India Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Herpes Zoster Ophthalmicus Drug Revenue, 2017-2028
  6.6.2 Brazil Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.6.3 Argentina Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Herpes Zoster Ophthalmicus Drug Revenue, 2017-2028
  6.7.2 Turkey Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.7.3 Israel Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028
  6.7.5 UAE Herpes Zoster Ophthalmicus Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.1.4 Abbott Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.2.4 Novartis Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.3.4 GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Fresenius
  7.4.1 Fresenius Corporate Summary
  7.4.2 Fresenius Business Overview
  7.4.3 Fresenius Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.4.4 Fresenius Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.4.5 Fresenius Key News
7.5 SteriMax
  7.5.1 SteriMax Corporate Summary
  7.5.2 SteriMax Business Overview
  7.5.3 SteriMax Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.5.4 SteriMax Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.5.5 SteriMax Key News
7.6 Cadila Pharmaceuticals
  7.6.1 Cadila Pharmaceuticals Corporate Summary
  7.6.2 Cadila Pharmaceuticals Business Overview
  7.6.3 Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.6.4 Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.6.5 Cadila Pharmaceuticals Key News
7.7 Shermco
  7.7.1 Shermco Corporate Summary
  7.7.2 Shermco Business Overview
  7.7.3 Shermco Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.7.4 Shermco Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.7.5 Shermco Key News
7.8 TEVA
  7.8.1 TEVA Corporate Summary
  7.8.2 TEVA Business Overview
  7.8.3 TEVA Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.8.4 TEVA Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.8.5 TEVA Key News
7.9 Cipla
  7.9.1 Cipla Corporate Summary
  7.9.2 Cipla Business Overview
  7.9.3 Cipla Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.9.4 Cipla Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.9.5 Cipla Key News
7.10 Mylan
  7.10.1 Mylan Corporate Summary
  7.10.2 Mylan Business Overview
  7.10.3 Mylan Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.10.4 Mylan Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.10.5 Mylan Key News
7.11 Foamix
  7.11.1 Foamix Corporate Summary
  7.11.2 Foamix Business Overview
  7.11.3 Foamix Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.11.4 Foamix Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.11.5 Foamix Key News
7.12 Merck
  7.12.1 Merck Corporate Summary
  7.12.2 Merck Business Overview
  7.12.3 Merck Herpes Zoster Ophthalmicus Drug Major Product Offerings
  7.12.4 Merck Herpes Zoster Ophthalmicus Drug Revenue in Global Market (2017-2022)
  7.12.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Herpes Zoster Ophthalmicus Drug Market Opportunities & Trends in Global Market
Table 2. Herpes Zoster Ophthalmicus Drug Market Drivers in Global Market
Table 3. Herpes Zoster Ophthalmicus Drug Market Restraints in Global Market
Table 4. Key Players of Herpes Zoster Ophthalmicus Drug in Global Market
Table 5. Top Herpes Zoster Ophthalmicus Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Herpes Zoster Ophthalmicus Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Herpes Zoster Ophthalmicus Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Herpes Zoster Ophthalmicus Drug Product Type
Table 9. List of Global Tier 1 Herpes Zoster Ophthalmicus Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Herpes Zoster Ophthalmicus Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Herpes Zoster Ophthalmicus Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Herpes Zoster Ophthalmicus Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Herpes Zoster Ophthalmicus Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Herpes Zoster Ophthalmicus Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Herpes Zoster Ophthalmicus Drug Product Offerings
Table 32. Abbott Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Herpes Zoster Ophthalmicus Drug Product Offerings
Table 35. Novartis Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Product Offerings
Table 38. GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 39. Fresenius Corporate Summary
Table 40. Fresenius Herpes Zoster Ophthalmicus Drug Product Offerings
Table 41. Fresenius Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 42. SteriMax Corporate Summary
Table 43. SteriMax Herpes Zoster Ophthalmicus Drug Product Offerings
Table 44. SteriMax Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 45. Cadila Pharmaceuticals Corporate Summary
Table 46. Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Product Offerings
Table 47. Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 48. Shermco Corporate Summary
Table 49. Shermco Herpes Zoster Ophthalmicus Drug Product Offerings
Table 50. Shermco Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 51. TEVA Corporate Summary
Table 52. TEVA Herpes Zoster Ophthalmicus Drug Product Offerings
Table 53. TEVA Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 54. Cipla Corporate Summary
Table 55. Cipla Herpes Zoster Ophthalmicus Drug Product Offerings
Table 56. Cipla Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 57. Mylan Corporate Summary
Table 58. Mylan Herpes Zoster Ophthalmicus Drug Product Offerings
Table 59. Mylan Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 60. Foamix Corporate Summary
Table 61. Foamix Herpes Zoster Ophthalmicus Drug Product Offerings
Table 62. Foamix Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)
Table 63. Merck Corporate Summary
Table 64. Merck Herpes Zoster Ophthalmicus Drug Product Offerings
Table 65. Merck Herpes Zoster Ophthalmicus Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Herpes Zoster Ophthalmicus Drug Segment by Type in 2021
Figure 2. Herpes Zoster Ophthalmicus Drug Segment by Application in 2021
Figure 3. Global Herpes Zoster Ophthalmicus Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Herpes Zoster Ophthalmicus Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Herpes Zoster Ophthalmicus Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Herpes Zoster Ophthalmicus Drug Revenue in 2021
Figure 8. By Type - Global Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 12. US Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 16. Germany Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 24. China Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Herpes Zoster Ophthalmicus Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Herpes Zoster Ophthalmicus Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fresenius Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. SteriMax Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cadila Pharmaceuticals Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Shermco Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. TEVA Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cipla Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mylan Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Foamix Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Merck Herpes Zoster Ophthalmicus Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)